Cap for container
Latest Glaxo Group Limited Patents:
- Method of producing a recombinant protein
- Antigen binding proteins
- Pharmaceutical formulations comprising 4-{(1R)-2-[(6-{2-[(2,6-dichlorobenzyl)oxy]ethoxy}hexyl)amino]-1-hydroxyethyl}-2-(hydroxymethyl) phenol
- Combinations of a muscarinic receptor antagonist and a beta-2 adrenoreceptor agonist
- Compounds
Description
FIG. 1 is a front perspective view from above and one side of a cap for container showing our new design;
FIG. 2 is a front view;
FIG. 3 is a rear view;
FIG. 4 is a view of other side;
FIG. 5 is a plan view; and,
FIG. 6 is an underneath plan view.
Claims
We claim the ornamental design for a cap for container, as shown and described.
Referenced Cited
U.S. Patent Documents
Patent History
Patent number: D525868
Type: Grant
Filed: Dec 21, 2004
Date of Patent: Aug 1, 2006
Assignee: Glaxo Group Limited (Middlesex)
Inventors: Günter Kolanus (Hattersheim), Louis Anthony Massari (Surrey)
Primary Examiner: Robert M. Spear
Assistant Examiner: Susan Bennett Hattan
Attorney: Nora Stein-Fernandez
Application Number: 29/219,745
Type: Grant
Filed: Dec 21, 2004
Date of Patent: Aug 1, 2006
Assignee: Glaxo Group Limited (Middlesex)
Inventors: Günter Kolanus (Hattersheim), Louis Anthony Massari (Surrey)
Primary Examiner: Robert M. Spear
Assistant Examiner: Susan Bennett Hattan
Attorney: Nora Stein-Fernandez
Application Number: 29/219,745
Classifications
Current U.S. Class:
D9/445